While a relationship between dopamine and ethanol is widely accepted, this interaction remains relatively undocumented in primates, including humans. The proposed research is critical to the understanding of factors influencing the association between ethanol reinforcement and midbrain dopamine response. Background studies suggest that one mechanism by which ethanol can affect dopaminergic function if through modulation of GABAergic tone in the central nervous system. It is known that the endogenous neurosteroid allopregnanolone acts as a positive modulator of GABAA/benzodiazepine receptors and shares significant overlap with ethanol in producing similar discriminative stimulus effects. There is also evidence that there may be a sex difference in sensitivity to the ethanol-like stimulus effects of allopreganolone. Based on our current knowledge of the interactions between ethanol, dopamine and neurosteroids we hypothesize that we can use positron emission tomography (PET) to document ethanol's increase synaptic dopamine under acute exposure and that these effects of ethanol will be mimicked by allopregnanolone. Further, we hypothesize that chronic ethanol self-administration of ethanol will result in a neuroadaptation of dopaminergic response, reflected in a functional down-regulation of D2 receptor availability. Finally, we hypothesize that the neuroadaptation to ethanol will be slowly reversed by abstinence from ethanol self-administration. With this model and the proposed PET methodology, we can explore neuroadaptation of midbrain dopamine neurons to chronic ethanol self-administration in a longitudinal study. Thus, this research provides a critical step in the understanding the mechanisms underlying the association between dopamine and ethanol reinforcement.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA011997-02
Application #
6299194
Study Section
Project Start
2000-01-01
Project End
2000-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
2000
Total Cost
$323,496
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Davenport, April T; Grant, Kathleen A; Szeliga, Kendall T et al. (2014) Standardized method for the harvest of nonhuman primate tissue optimized for multiple modes of analyses. Cell Tissue Bank 15:99-110
Freeman, Willard M; Vanguilder, Heather D; Guidone, Elizabeth et al. (2011) Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration. Int J Neuropsychopharmacol 14:899-911
Lyn, Heidi; Pierre, Peter; Bennett, Allyson J et al. (2011) Planum temporale grey matter asymmetries in chimpanzees (Pan troglodytes), vervet (Chlorocebus aethiops sabaeus), rhesus (Macaca mulatta) and bonnet (Macaca radiata) monkeys. Neuropsychologia 49:2004-12
Graef, John D; Godwin, Dwayne W (2010) Intrinsic plasticity in acquired epilepsy: too much of a good thing? Neuroscientist 16:487-95
Freeman, Willard M; Salzberg, Anna C; Gonzales, Steven W et al. (2010) Classification of alcohol abuse by plasma protein biomarkers. Biol Psychiatry 68:219-22
Cheng, Heng-Jie; Grant, Kathleen A; Han, Qing-Hua et al. (2010) Up-regulation and functional effect of cardiac ?3-adrenoreceptors in alcoholic monkeys. Alcohol Clin Exp Res 34:1171-81
McCauley, Anita K; Frank, Steven T; Godwin, Dwayne W (2009) Brainstem nitrergic innervation of the mouse visual thalamus. Brain Res 1278:34-49
Shively, Carol A; Mietus, Joseph E; Grant, Kathleen A et al. (2007) Effects of chronic moderate alcohol consumption and novel environment on heart rate variability in primates (Macaca fascicularis). Psychopharmacology (Berl) 192:183-91
Walker, Stephen J; Wang, Yulei; Grant, Kathleen A et al. (2006) Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates. J Neurosci Methods 152:179-89
Freeman, Willard M; Gooch, Randy S; Lull, Melinda E et al. (2006) Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol Alcohol 41:300-5

Showing the most recent 10 out of 33 publications